时间：2025-10-23 16:47:46 来源：网络整理编辑：時尚
The Food and Drug Administration has approved the first pill embedded with a sensor that can alert a
The Food and Drug Administration has approved the first pill embedded with a sensor that can alert a patient’s physician or caregiver when it’s been ingested, the agency announced on Monday.
The Japanese drug maker Otsuka Pharmaceutical won the approval for an upgraded version of Abilify, the antipsychotic drug first approved 15 years ago to treat schizophrenia, bipolar disorder, and depression. Otsuka collaborated with Proteus Digital Health, the Silicon Valley company that designed the futuristic sensor technology.
SEE ALSO:Big Pharma’s big push to get patients to take their medsThe new product, which will be sold as Abilify MyCite, can be swallowed just like any other pill. When that happens, the ingestible sensor inside it sends a message to a patch worn by the patient, which then transmits the information to a mobile app that the patient can monitor. If a patient opts to allow it, the patient’s caregivers and doctor can access the data online, too.
The FDA’s decision Monday comes a year and a half after the agency rejected the product. At the time, the agency said it needed more information about how the product is used and how human error could create risks. Monday’s hard-won approval could come as a big boost for Otsuka, which had lost market share after Abilify went generic but will now have a way to make the product stand out.
Forgetfulness and cloudy thinking can be symptoms of the mental health conditions that Abilify is approved to treat, and patients with mental illness are known to struggle to take medication consistently. But the new product will also be labeled with a caveat: There’s no evidence that the technology can help patients take their medication as prescribed.
The landmark approval is the latest in an expansive rethinking of what constitutes a treatment. In September, the FDA approved the first mobile app to treat certain substance use disorders, developed by the Boston company Pear Therapeutics.
TopicsHealth
Olympian celebrates by ordering an intimidating amount of McDonald's2025-10-23 16:39
Breaking bad news is always tricky. Behold, the absolute worst ways to do it.2025-10-23 16:14
20 Instagram2025-10-23 15:52
Look! No hands (or feet) needed to fly this autonomous helicopter.2025-10-23 15:51
Honda's all2025-10-23 15:51
Oprah gifted an iPhone to a fan after dunking on his cracked screen2025-10-23 15:49
Apple is testing a way to completely turn off location tracking in iOS2025-10-23 15:32
Oprah gifted an iPhone to a fan after dunking on his cracked screen2025-10-23 15:27
Australian football makes history with first LGBT Pride Game2025-10-23 15:00
Bang & Olufsen's new wireless earbuds are improved in every way that matters2025-10-23 14:43
Twitter grants everyone access to quality filter for tweet notifications2025-10-23 16:32
The viral TikTok of a teen eating a 102025-10-23 16:29
Experts skeptical that Facebook Preventive Health will have an impact2025-10-23 15:34
This is the best time in human history. We're designed to think otherwise.2025-10-23 15:32
Here's George Takei chilling in zero gravity for the 'Star Trek' anniversary2025-10-23 15:05
YouTubers band together to plant 20 million trees to fight climate change2025-10-23 15:00
'Miss Americana' won't change your mind about Taylor Swift: Review2025-10-23 14:59
2019 was the year of the chicken sandwich2025-10-23 14:41
Over 82,000 evacuate as Blue Cut fire rapidly spreads in southern California2025-10-23 14:22
Outsmart polar vortices with 15% off The North Face at The House2025-10-23 14:01
